Table 2.
Control (n = 61) | Mild OSAS (n = 67) | Moderate OSAS (n = 61) | Severe OSAS (n = 101) | ANOVA p | |
---|---|---|---|---|---|
AHI | 1.91 ± 1.69 | 9.14 ± 3.03* | 21.5 ± 4.98*,+ | 72.5 ± 51.7*,+ | <0.001 |
Sleep efficiency, % | 81.0 ± 9.14 | 81.0 ± 9.91 | 82.0 ± 10.3 | 77.1 ± 13.1* | 0.026 |
Total sleep time, min | 322.8 ± 44.8 | 298.7 ± 60.4 | 292.2 ± 62.4 | 257.0 ± 78.2* | <0.001 |
Stage 1, min | 58.2 ± 32.0 | 39.5 ± 37.9 | 48.2 ± 53.7 | 73.5 ± 59.8* | 0.006 |
Stage 2, min | 139.6 ± 71.8 | 103.2 ± 67.3 | 125.7 ± 69.6 | 70.9 ± 43.30* | <0.001 |
Baseline SaO2, % | 97.3 ± 0.96 | 95.5 ± 1.77 | 93.9 ± 3.07 | 92.0 ± 4.87* | <0.001 |
Lowest SaO2, % | 91.3 ± 3.09 | 88.4 ± 3.82 | 81.3 ± 8.68* | 79.0 ± 8.87* | <0.001 |
ESS | 8.7 ± 4.6 | 8.9 ± 5.2 | 10.4 ± 5.9 | 11.6 ± 6.0* | 0.029 |
AHI: apnea-hypopnea index; ESS: Epworth sleepiness scale
*p < 0.05 vs. control group, +p < 0.05 vs. mild OSAS group